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Abstract
Background: In primates, infection is an important force driving gene evolution, and this is
reflected in the importance of infectious disease in human morbidity today. The beta-defensins are
key components of the innate immune system, with antimicrobial and cell signalling roles, but also
reproductive functions. Here we examine evolution of beta-defensins in catarrhine primates and
variation within different human populations.
Results: We show that five beta-defensin genes that do not show copy number variation in
humans show evidence of positive selection in catarrhine primates, and identify specific codons that
have been under selective pressure. Direct haplotyping of DEFB127 in humans suggests long-term
balancing selection: there are two highly diverged haplotype clades carrying different variants of a
codon that, in primates, is positively selected. For DEFB132, we show that extensive diversity,
including a four-state amino acid polymorphism (valine, isoleucine, alanine and threonine at position
93), is present in hunter-gatherer populations, both African and non-African, but not found in
samples from agricultural populations.
Conclusion: Some, but not all, beta-defensin genes show positive selection in catarrhine primates.
There is suggestive evidence of different selective pressures on these genes in humans, but the
nature of the selective pressure remains unclear and is likely to differ between populations.
Background
A rapid response to counter and contain microbial infec-
tion is provided by the innate immune system in all mul-
ticellular organisms. A key component of the innate
immune response is the broad spectrum of antimicrobial
proteins that can either be constitutively expressed on epi-
thelia or be induced during inflammation [1,2]. There is
evidence for extensive diversity of antimicrobial proteins,
with different genes arising by duplication followed by
positive adaptive selection [3-5]. Analysing the history of
duplication and sequence variation of these antimicrobial
genes will help us to understand how selection by infec-
tious diseases has led to functional adaptation at the
molecular level.
The beta-defensins are a family of genes which has key
roles in the innate immune response, such as antimicro-
bial activity, antiviral activity and signalling [1]. Some
members have also been shown to have an important role
in reproduction – for example the protein encoded by
DEFB126 coats the sperm surface and mediates attach-
ment of the sperm to the oviduct [6,7]. Evolutionary anal-
yses of the beta-defensins have produced evidence for
repeated rounds of duplication and divergence of the
mature peptide by positive selection. Most convincing are
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studies which show rapid duplication and divergence of
beta-defensin genes since mouse and rat divergence, sup-
porting a birth-and-death model for beta-defensin evolu-
tion in the rodents [8,9].
Infectious disease is likely to have been a major selective
agent in human evolution [10]. Changes of habitat and of
social system during evolution of hominids, and other
primates, alter the spectrum of infectious diseases encoun-
tered at different times and by different species. Aspects of
more recent human evolution are also likely to have been
driven by infectious disease: archaeological evidence sug-
gests that individuals in agricultural populations would
have suffered more from "crowd diseases" compared to
hunter-gatherers, due to the proximity of domestic ani-
mals and of each other [11,12]. As well as an increase in
infectious disease, the transition from hunter-gatherer to
farmer is likely to have had an effect on the genes of the
different populations in other ways, such as changes in
diet and reproductive behaviour [13].
In order to understand the evolutionary pressures on beta-
defensins in primates, we determined putative ortho-
logues of human beta-defensins from six other catarrhine
primate species: chimpanzee (Pan troglodytes), gorilla
(Gorilla gorilla), orangutan (Pongo pygmaeus), gibbon
(Hylobates lar), long-tailed macaque (Macaca fascicularis)
and rhesus macaque (Macaca mulatta) .  W e  u s e d  t h e
known branching order of the primate phylogeny,
together with a maximum-likelihood approach using dif-
ferent models of evolution, to test whether positive selec-
tion has acted on these genes. Analysing selection in the
catarrhine lineage allowed us to identify specific codons
in certain beta-defensins that showed a response to envi-
ronmental change over the last 25 million years. By ana-
lysing the variation in these genes in a cohort of hunter-
gatherer and agricultural human populations, we infer
their more recent evolution and discuss whether popula-
tion-specific selection processes are responsible for the
patterns of variation.
Results
Comparative sequence analysis
The beta-defensin gene family is defined by a six-cysteine
core motif (C-X6-C-X4-C-X9-C-X6-C-C) which was previ-
ously used as a motif to search the genome for additional
beta-defensins [14]. Some of these were confirmed to
encode full-length mRNA transcripts and code for pro-
teins whose amino acid sequence differed considerably
outside the shared core motif [14,15]. This coding
sequence difference between beta-defensin genes contin-
ues into intronic sequence, so that both coding sequence
and intronic sequence can define clear orthologues
between humans, chimpanzees and rhesus macaques. In
addition, according to the current genome assemblies
(panTro2 and rheMac2) the expected syntenic relation-
ships are maintained across these three species. By design-
ing primers in non-coding sequences that clearly
distinguish between beta-defensin genes, we identified
and sequenced putative orthologues in six primate species
of coding sequences for all 17 beta-defensin genes for
which full-length transcript evidence existed in humans at
the start of the project (supplementary figure 1; sequence
accession numbers given in supplementary table 1).
Using the information from the known phylogeny of the
primate species, we assessed the orthologous sequences
for evidence of positive selection. We analysed the ratio
(ω) between the non-synonymous substitution rate and
the synonymous substitution rate, using a maximum-like-
lihood technique implemented by the program PAML.
This uses models that allow rates of evolution to vary
between codons, so allowing the identification of specific
positions likely to have undergone positive selection
[16,17]. Five genes showed evidence of positive selection:
DEFB1,  DEFB118,  DEFB120,  DEFB127  and  DEFB132
(table 1). Codon 71 of DEFB127  has been positively
selected and is very variable between species (figure 1a),
and analysis of ancestral sequences suggests that this
codon has independently mutated five times during pri-
mate evolution (figure 1b).
Copy number analysis
We and others have previously shown a cluster of beta-
defensin genes (DEFB4, DEFB103, DEFB104, DEFB105,
DEFB106,  DEFB107) to be copy number variable in
humans; the neighbouring DEFB1 gene is not involved in
this copy number variation [18-20]. It is essential to
understand whether a gene is copy number variable in
order to correctly interpret apparently heterozygous SNP
sites, and to be aware of the possibility of gene conversion
between closely related paralogues.
We used multiplex amplifiable probe hybridisation
(MAPH) to examine whether other members of the beta-
defensin family varied in copy number, in addition to
those previously described. MAPH is a method for gene
copy number analysis that relies on quantitative recovery
of amplifiable probes following hybridisation to genomic
DNA [21,22]. Using MAPH probes for the beta-defensin
gene regions analysed in this study, we asked whether
there was any evidence of copy number variation in the 37
DNA samples used for the population analyses described
in this paper, and in a further 153 individuals from the
UK. We reasoned that variation between duplicate tests of
individuals would be highly correlated where underlying
copy number variation was the main cause of the varia-
tion, but less correlated, if at all, when the main cause was
random experimental noise. The correlation between the
two sets of raw MAPH results for 190 samples was calcu-BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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lated, and the probes mapping to the copy number varia-
ble region at 8p23.1 showed high correlation coefficients
(0.70<r<0.96). All other beta-defensin probes showed
correlation coefficients less than 0.52 (supplementary
table 2), and there was no grouping of samples on scatter-
plots indicative of rarer deletion or duplication polymor-
phisms.
Population analyses
The second exon, which codes for the entire mature pep-
tide, was resequenced from all five beta-defensins that
showed positive selection, in a panel of 37 individuals
from four human populations. Twenty polymorphic sites
were found, of which 16 are predicted to change an amino
acid, and only 5 are present in dbSNP release 126
(rs16995685, rs12624954, rs2738047, rs16995668,
rs1800957 - please see NCBI webpage in Availability and
requirements section).
The number of synonymous and non-synonymous poly-
morphic sites and fixed differences between the human
and macaque exon 2 sequence was determined (table 2).
A McDonald-Kreitman test was performed on each gene,
and on the pooled results, to test for an excess of non-syn-
onymous fixed substitutions which suggests the influence
of positive selection of the gene [23]. None of the tests
showed significant evidence of selection (data not
shown), in contrast to the results obtained from the ω-
tests using PAML. This difference could be due to the
small number of changes and polymorphic sites in each
test, which is a reflection of the small size of the genes; but
pooling the data from all five genes also failed to show a
Analysis of DEFB127 evolution Figure 1
Analysis of DEFB127 evolution. a) Alignment of predicted amino acid sequences of primate DEFB127 proteins, together 
with the putative orthologue in dog and cow. Site 71 is highlighted. b) Phylogeny of the DEFB127 gene, with branch sites from 
the species phylogeny (see Methods) and branch lengths generated from the DEFB127 nucleotide data by maximum-likelihood. 
Branches showing codon changes corresponding to amino acid changes at site 71 are highlighted.BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
Page 4 of 14
(page number not for citation purposes)
significant result. More plausibly, the discrepancy could
be due to the high numbers of non-synonymous poly-
morphisms identified in humans (16 in total, compared
with 4 synonymous polymorphisms). Five of these are
singletons, but eleven were identified in two or more sam-
ples, suggesting that they may be at appreciable frequen-
cies in different populations.
We analysed the frequencies of the polymorphisms in
four different population samples: hunter-gatherers
Mbuti/Biaka (MB) and Indigenous Australian (IA), and
agriculturalists British (UK) and sub-Saharan African
(SSA) (table 2). A Fisher's exact test of independence
between Africans and non-Africans reveals significant dif-
ferences in allele frequency for many polymorphisms, as
expected. The strongest differences in allele frequencies
were for the R71S and G31R polymorphic sites in
DEFB127. Two DNA polymorphisms, both affecting
codon site 93 in DEFB132, showed significantly different
frequencies between agricultural and hunter-gather popu-
lations.
Analysis of DEFB127 and DEFB132
We decided to study the haplotype structure of both
DEFB127 and DEFB132 genes by complete resequencing.
For DEFB132, resequencing 292 bases spanning exon 2
from 74 chromosomes revealed 10 polymorphic sites
associating to form 14 haplotypes, inferred from diplo-
type data by maximum-likelihood analysis (supplemen-
tary table 3). For DEFB127, resequencing 3208 bases
spanning exons 1 and 2 in 74 human chromosomes
revealed 36 polymorphic sites associated to form 30 hap-
lotypes, determined unambiguously by allele-specific
PCR (supplementary table 4). We analysed the forces
affecting variation at different loci by calculating various
summary statistics from the haplotype data at both
DEFB127  and  DEFB132  in each population (table 3).
Both genes show high values for gene diversity (π), indi-
cating a high degree of heterozygosity in all populations.
There are four estimates of the population mutation
parameter (θ), derived from levels of homozygosity (θH),
number of segregating sites (θs), nucleotide diversity (θπ),
and the expected number of alleles (θk).
Tajima's D compares the distribution of rare frequency
alleles with intermediate frequency alleles by comparing
θs with θπ. DEFB127 gives a significantly negative value for
the MB and a significantly positive value for the UK pop-
ulation, which may indicate balancing selection. How-
ever, this statistic is known to be sensitive to demographic
changes: a negative value may result from a population
expansion and a positive value from population subdivi-
sion. Fay and Wu's H statistic compares the distribution of
common frequency alleles with intermediate frequency
alleles by comparing θH with θπ, and is more robust to
demographic changes [24]. For DEFB127, D, H, and Fu's
Fs are all significantly negative for the MB population,
which suggests directional selection in this population.
For DEFB127, Tajima's D is significantly positive in the
UK population reflection a signal of either balancing
selection or population subdivision.
Mismatch analysis
A mismatch distribution is a histogram showing the
number of mismatches when all haplotypes are compared
with each other, and describes the haplotype structure of
Table 1: Maximum-likelihood codon substitution analyses of beta-defensin genes in catarrhine primates
Location Gene Number of aligned 
codons
Likelihood Model M1a 
0<ω0<1, ω1 = 1
Likelihood Model M2a 
0<ω0<1, ω1 = 1, ω2>1
Positive selection P 
value
Selected sites 
(probability)
8p23.1 DEFB1 67 -397.25 -390.07 0.00076* R61 (0.997)
DEFB4 63 -401.51 -400.69 0.44
DEFB103 66 -334.85 -334.85 1.0
DEFB104 71 -407.87 -406.55 0.27
DEFB105 77 -509.99 -509.99 1.0
DEFB106 64 -353.50 -353.09 0.66
DEFB107 65 -343.19 -343.19 1.0
20q11 DEFB118 122 -734.34 -728.92 0.0044* R110 (0.967)
DEFB119 83 -501.92 -501.23 0.50
DEFB120 86 -485.55 -478.39 0.00077* M81 (0.998)
DEFB123 66 -289.31 -289.25 0.95
20p13 DEFB125 125 -779.12 -779.10 0.98
DEFB126 85 -591.65 -591.47 0.83
DEFB127 87 -498.13 -493.43 0.0091* S71 (0.984)
DEFB128 91 -526.11 -526.09 0.98
DEFB129 181 -946.41 -946.41 1.0
DEFB132 93 -594.10 -590.54 0.029* I57 (0.950)B
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Table 2: Human-macaque divergence and human coding polymorphisms of genes positively selected in catarrhine primates.
Gene Human – 
macaque non-
synonymous 
fixed changes
Human – 
macaque 
synonymous 
fixed changes
Human non-
synonymous 
polymorphisms
Human 
synonymous 
polymorphisms
Rs 
number
Human non-
synonymous 
polymorphic 
sites
Indigenous 
Australians
UK 
population
Other sub-
saharan 
Africans
Mbuti/Biaka Agriculturalists Hunter-
Gatherers
Fisher's exact 
test p value 
(not corrected 
for multiple 
tests)
African Non-African Fisher's exact 
test p value (not 
corrected for 
multiple tests)
DEFB127 8 6 4 1 169956
85
R71S 4 8 0 1 8 5 0.175 1 12 0.002
- R71H 0 0 0 2 0 2 0.288 2 0 0.208
126249
54
G31R 4 8 0 1 8 5 0.175 1 12 0.002
- K58R 0 0 1 0 1 0 0.459 1 0 0.459
DEFB120 13 2 3 0 - H28R 0 0 1 3 1 3 0.371 4 0 0.040
- R46C 1 0 0 0 0 1 0.541 0 1 0.541
- *89EL* 0 0 1 3 1 3 0.371 4 0 0.040
DEFB132 12 8 5 2 - W41S 0 0 1 2 1 2 0.561 3 0 0.092
- P63Q 0 0 3 1 3 1 0.248 4 0 0.040
- L70F 0 0 1 2 1 2 0.561 0 3 0.152
- V93I/T 4 0 0 2 0 6 0.021 2 4 0.418
- V93A/T 3 0 1 9 1 12 0.002 10 3 0.015
DEFB118 11 7 2 0 - C34R 0 1 0 0 1 0 0.459 0 1 0.541
- I56V 0 0 1 4 1 4 0.234 5 0 0.017
DEFB1 6 7 2 1 - F24C 0 0 0 1 0 1 0.541 1 0 0.459
273804
7
V38I 0 0 0 1 0 1 0.541 1 0 0.459
n 50 30 16 4 - 16 20 20 14 20 34 40 - 34 40 -BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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a region. Figure 2a shows the mismatch distributions for
DEFB127 and figure 2b shows the mismatch distributions
for DEFB132. On each graph the expected distribution
given neutrality with a constant population size is shown
(dashed line), and the expected distribution given a recent
population expansion is also shown (solid line).
For  DEFB127, all distributions are characterised by a
strong bimodal pattern inconsistent with a model reflect-
ing neutrality, constant population size or a population
expansion. In each distribution, the second peak is at
around 20 differences, with the exception of SSA, where
the second peak is at around 8 differences. The strongest
bimodal distribution is in the UK population, reflecting
two deep haplotype clades at similar frequency, and sug-
gests balancing selection at this locus in this population.
This supports the result from the Tajima's D test. For
DEFB132, the SSA, UK and MB populations show a bimo-
dal distribution also inconsistent with a model reflecting
neutrality, constant population size or a population
expansion. For the IA population, the distribution is more
consistent with neutrality, either with a constant popula-
tion size or an expansion.
Network analysis
Network diagrams can be used to show haplotype struc-
ture graphically. Each haplotype is a node on the diagram
linked to other haplotypes that differ by one nucleotide
position. They also convey haplotype frequency and dis-
tribution information by the size and composition of the
pie chart at each node. Analysis of the haplotype network
for DEFB127 reveals that the bimodal mismatch distribu-
tion reflects haplotypes carrying a glycine at position 31
and an arginine at position 71 (G31R71) and a highly
diverged haplotype clade carrying an arginine at position
31 and a serine at position 71 (R31S71) (figure 3a).
The DEFB132 haplotypes are shown on a network dia-
gram together with the root haplotype (figure 3b). There
are four coding alleles at codon 93: valine, which is ances-
tral and the most common; alanine, which is observed in
MB population and one SSA individual; threonine, seen
only in the IA and MB; and isoleucine, seen in one IA indi-
vidual. This suggests that some ancient haplotypes carry-
ing the coding variation at codon 93 have persisted in
geographically dispersed hunter-gatherer populations.
This could be due to absence of purifying selection that
has operated in agricultural populations [25]. The net-
work shows a reticulation and several branches caused
either by recurrent mutation or recombination – only pol-
ymorphisms 4, 5, 6 and 7 occur on one branch of the net-
work.
Table 3: Within-population diversity metrics for DEFB127 and DEFB132. p values are shown when less than 0.05, error values represent 
standard deviations unless otherwise indicated
Gene Metric Indigenous Australians UK Other sub-Saharan Africans Mbuti/Biaka
DEFB127 nucleotides 3210 3210 3210 3210
Gene Diversity 0.72 +/- 0.089 0.83 +/- 0.057 0.97 +/- 0.036 0.95 +/- 0.033
Segregating sites 22 22 13 30
Nucleotide diversity (π) ×10-3 2.3 +/- 1.3 3.2 +/- 1.7 1.4 +/- 0.8 1.5 +/- 0.8
θH 2.0 +/- 0.93 4.0 +/- 1.8 28 +/- 33 18 +/- 14
θs 6.2 +/- 2.4 6.5 +/- 2.5 4.1 +/- 1.8 8.4 +/- 3.2
θπ 7.5 +/- 4.1 10 +/- 5.5 4.5 +/- 2.6 4.7 +/- 2.7
θk (95% confidence limits) 2.5 (0.97 – 6.2) 4.4 (1.8 – 10) 22 (8 – 66) 19 (8.2 – 47)
Fu's Fs 4.63 3.63 -4.35 -5.38 (p = 0.013)
Tajima's D 0.82 2.27 (p = 0.030) 0.38 -1.72 (p = 0.030)
Fay and Wu's H -2.31 1.05 -0.13 -9.61 (p = 0.019)
Nucleotide divergence human-chimp % 1.2+/-0.2
DEFB132 nucleotides 292 292 292 292
Gene Diversity 0.69 +/- 0.11 0.56 +/- 0.063 0.73 +/- 0.10 0.87 +/- 0.048
Segregating sites 5 7 7 10
Nucleotide diversity (π) ×10-3 6.9 +/- 4.5 5.5 +/- 3.8 7.2 +/- 4.8 10.3 +/- 6.3
θH 0.97 +/- 0.25 1.7 +/- 0.87 2.0 +/- 1.1 5.8 +/- 2.7
θs 1.1 +/- 0.65 1.4 +/- 0.76 2.5 +/- 1.2 2.5 +/- 1.2
θπ 1.6 +/- 1.1 2.0 +/- 1.3 2.1 +/- 1.4 3.0 +/- 1.8
θk (95% confidence limits) 0.72 (0.21 – 2.3) 3.4 (1.4 – 8.1) 2.3 (0.81 – 6.4) 4.4 (1.8 – 10)
Tajima's D 1.29 1.25 -0.62 0.65
Fu's Fs -1.20 2.51 0.19 -0.83
Fay and Wu's H -0.095 0.35 -2.42 -0.60
Nucleotide divergence human-chimp % 2.8+/-1.0
Number of chromosomes 20 20 14 20BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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Mismatch analysis of DEFB127 and DEFB132 haplotypes Figure 2
Mismatch analysis of DEFB127 and DEFB132 haplotypes. Mismatch analysis plots are shown for each population, 
together with a simulated plot assuming neutrality and a sudden population expansion. 95% Confidence intervals to the simu-
lated values were determined by bootstrap analysis. a) DEFB127. b)DEFB132.
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Network diagram of haplotypes Figure 3
Network diagram of haplotypes. Pie size is proportional to number of observations of each haplotype. The number on 
each branch reflects the polymorphic site, as indicated in supplementary tables 3 and 4. Branches that change an amino acid are 
also highlighted with that change. a) DEFB127. b) DEFB132.BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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Genomic region analysis
Analysis using HapMap data [26] shows that both
diverged DEFB127 haplotypes are present in European,
Chinese and Japanese, extending as an essentially non-
recombining haplotype block for about 25 kb, but neither
the R31S71 haplotype nor its constituent alleles are found
in the Yoruba from Nigeria (data not shown). Using the
CEPH HapMap data, an EHH test was performed to ana-
lyse for signatures of recent selection [27]. No haplotype
has extended haplotype homozygosity with respect to the
other, suggesting that the observed frequencies were not
generated by recent positive selection for one or other
haplotype (data not shown). It is unclear why the R31S71
haplotype is not seen in the SSA population nor in the
Nigerian Yoruba HapMap population. There are three
possible explanations: that it has been carried across the
world in the out of Africa expansion, and has been lost in
certain populations by drift; that it has been maintained
in certain populations by balancing selection; or it is a
product of a relatively recent hybridisation event.
To exclude selection at another linked gene being respon-
sible for this haplotype pattern, we first examined the
extent of linkage disequilibrium across this region in the
CEPH HapMap samples. The only other gene on the same
haplotype block, and therefore possibly associated with
DEFB127, was DEFB126, 15 kb away. Resequencing of
exon 2 of DEFB126 found two deletion polymorphisms
which substantially altered the C-terminal tail amino acid
sequence of DEFB126 (Hollox and Armour, unpublished
data). These were candidate functional polymorphisms
that could have caused a selective sweep affecting poly-
morphism frequencies and association at DEFB127. To
investigate this, we genotyped 141 Northern European
individuals for the two polymorphisms at DEFB127
(G31R and R71S) and the two deletion polymorphisms in
DEFB126. Maximum-likelihood estimation found no evi-
dence of linkage disequilibrium between the markers at
DEFB127 and at DEFB126 (r2 = 0.05), although there was
very strong association (r2 = 0.98) between the two poly-
morphic sites within DEFB127 (data not shown). There-
fore there is no evidence of a selective sweep driven by
these variant alleles at DEFB126.
Discussion
We have identified five beta-defensin genes that have
undergone positive selection in primates, including
DEFB118 and DEFB1, whose protein products show evi-
dence of direct antimicrobial action in urogenital tissues
[28,29]. The selected position in DEFB1 has been shown
to be directly involved in antimicrobial activity and sig-
nalling [30], and natural selection has modulated its
charge and polarity in response to the microbial environ-
ment. The results broadly agree with a previous analysis of
the 8p23.1 cluster [31]: we agree that there is no support
for the previously suggested effect of selection on the
amino acid sequence of DEFB4 [32]. More generally, we
note that the genes on 8p23.1 that are variable in copy
number among humans show no evidence of positive
selection in the last 25 million years. This could be
because the copy number variable beta-defensins tend to
be shorter, and the analyses lack power when analysing
short coding sequences. Alternatively, there could be a
causal association between copy number variation and
the likelihood of coding sequence diversification by posi-
tive selection. In primates and the dog, the chromosome
8 cluster does not seem to have undergone as much dupli-
cation and rapid divergence since species divergence as
rodents [31,33]. In horses, there appears to have been a
rapid duplication and divergence of the DEFB4  ortho-
logue [34], and a similar process may have occurred in
goats [35]. It also appears that the DEFB106 and DEFB107
orthologues have been positively selected in the Old
World Monkey Cercopithecus aethiops [31], so further
investigation in different catarrhine clades, as well as pla-
tyrrhines and other primates, is necessary. The question
remains whether, in copy number variable genes, exten-
sive divergence is prevented by purifying selection and
gene conversion, or by balancing selection maintaining a
pool of similar variants that are shuffled by gene conver-
sion. Determining whether the same loci are copy number
variable loci between different primates, and whether
copy number variation exists in other mammals, will help
to answer this question.
We have used a top-down evolutionary approach to iden-
tify variation in genes that is likely to be functional, and
has been driven by selection. In doing so, we have
revealed high levels of beta-defensin diversity in human
populations, but the forces driving this diversity are diffi-
cult to identify. DEFB127 diversity involves two positions
that distinguish two deep-rooting haplotypes, suggesting
that there are epistatic interactions between the two
amino acids and that both haplotypes have been pre-
served by balancing selection. Balancing selection has
been suggested to maintain variation at several other
innate immune genetic loci, such as CD209L cell-surface
receptor [36] and the killer immunoglobulin-like recep-
tors (KIR) [37], and at loci involved in reproduction, such
as zonadhesin [38]. By chemical synthesis, reconstruction
and folding of the core N-terminal sequence, DEFB127
was shown not to have antimicrobial activity [39]. How-
ever,  DEFB127, like several other beta-defensins, is
expressed in the epidydimis and may be involved in
sperm maturation or reproduction. Evidence for direc-
tional selection in the Mbuti/Biaka population indicates
contrasting selection pressures in different populations
due the different environmental pressures that these pop-
ulations have faced. Whether balancing selection has been
a major force in the human genome is disputed, and dis-BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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tinguishing signatures of balancing selection from neutral
variation is difficult without a clear prior hypothesis con-
cerning the potential mechanism of balancing selection in
a given candidate gene [40].
DEFB132 has been positively selected in the catarrhine
lineage, and is highly variable in human populations.
However, in humans there is only evidence from mis-
match distribution analysis of any statistical departure
from neutral evolution at this locus, though the power of
the analyses could be limited by the small region ana-
lysed. One codon is polymorphic in hunter gatherer pop-
ulations, coding for four amino acids (V/A/T/I), but in
agricultural populations 39 out of 40 chromosomes carry
a valine at this position. Genetic differentiation tests
reveal a similar contrast between agricultural and hunter-
gatherer populations; as expected African and non-African
populations are significantly differentiated for both
DEFB127 (Hst permutation test, p = 0.008) and DEFB132
(p < 0.0001), but for DEFB132 the agricultural and non-
agricultural populations are also differentiated (p <
0.0001). The basis for any selective pressure is
unclear:DEFB132 is expressed in the testis, and possibly
elsewhere, is secreted and is likely to be antimicrobial
although that has not been directly tested [15].
We have shown that beta-defensins have different pat-
terns of selection, and one of the selected amino acids has
been shown to be antimicrobial and involved in cell-cell
signalling. The challenge will be to relate evolutionary
changes in amino acid sequences to differences in antimi-
crobial, cell-signalling or sperm function. Both a compre-
hensive picture of the evolution of these genes by
identifying orthologues in other mammalian species, and
a concurrent effort into characterising the function of
these orthologues, is needed in order to fully understand
the role of this gene family in innate immunity and repro-
duction.
Conclusion
Several beta-defensin genes show positive selection in
catarrhine primates, including DEFB127, DEFB118  and
DEFB1, but not the beta-defensin genes involved in com-
mon copy number variation on chromosome 8p23.1.
There is suggestive evidence of different selective pressures
on these genes in humans, with DEFB127 showing evi-
dence of balancing selection. Given the multifunctional
role of the beta-defensin family, however, the nature of
the selective pressure remains unclear and is likely to dif-
fer between populations.
Methods
DNA samples
Genomic DNA from five primates (Macaca fascicularis –
long-tailed macaque, Hylobates lar – gibbon, Pongo pyg-
maeus – orangutan, Gorilla gorilla – lowland gorilla, Pan
troglodytes  – common chimpanzee) was extracted from
lymphoblastoid cell lines at the European Collection of
Animal Cell Cultures (ECACC, Salisbury, UK). DNA from
10 native British individuals (UK) was chosen randomly
from the ECACC control panel 1, DNA from 10 Indige-
nous Australian individuals (IA) and 7 sub-Saharan Afri-
cans (SSA, 5 Zulu, 1 Kikuyu, 1 Ghanaian) was obtained
from ECACC, and DNA from 10 Mbuti/Biaka "Pygmy"
individuals living in the Democratic Republic of Congo
(MB) was obtained from Coriell Cell Repositories (New
Jersey, USA). DNA from 153 British individuals resident
in non-urban Nottinghamshire was used for copy number
analysis, and was from a cohort described previously [41].
PCR, sequencing, and copy number analysis
20 ng of genomic DNA was amplified using a standard
PCR mix: 0.2 mM each of dATP, dCTP, dGTP, dTTP, 1 mM
MgCl2, 75 mM Tris-HCl (pH 8.8 at 25°C), 20 mM
(NH4)2SO4, 0.01% (v/v) Tween 20 in a final volume of 20
μl, with 10 pmol of each primer, 0.5 units Taq DNA
polymerase (ABgene), followed by thermal cycling for 35
cycles at 95°C 30 seconds, 58°C 1 minute 70°C 1 minute.
Amplification from human DNA successfully produced a
single band and lower annealing temperature (typically
5°C less than the calculated Tm at 50 mM salt) for the first
5 cycles was used to minimise the risk of unexpected
allele- or paralogue-specific amplification in non-human
samples. If, after repeated reduction in annealing temper-
ature, amplification did not result in a single band, prim-
ers were redesigned. In a few cases, amplification products
could not be generated.
PCR products were prepared for sequencing either using a
Gel Extraction kit (Qiagen), eluted in water, or the
Ampure SPRI method (Agencourt Bioscience). 5 μl of the
solution (~100–250 ng) was then sequenced using
BigDye 3.1, following the manufacturer's instructions
(Applied Biosystems). Free dye was removed either by eth-
anol precipitation, or by the Cleanseq SPRI method
(Agencourt Bioscience). Sequencing reactions were elec-
trophoresed on an ABI 3730 capillary sequencer by the
DNA Sequencing Service at the Biochemistry Department,
University of Oxford, and analysed manually using
FinchTV (Geospiza). Putative orthologue coding
sequences were assembled by alignment with human
sequences and submitted to EMBL sequence database
(accession numbers in supplementary table 1). In all
cases, human DNA was amplified and sequenced using
the same primers as for the other primates, and confirmed
to be from the correct gene using BLAT against the human
genome assembly build 34. M. mulatta orthologues were
identified from the genome assembly by BLAT searching
using the M. fascicularis DNA sequence. In all cases, one
unique match was identified.BMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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Population resequencing was carried out essentially as
above. All polymorphic sites which were only seen as het-
erozygotes or singletons were sequenced off both strands
in those individuals.
Multiplex Amplifiable Probe Hybridisation (MAPH) and
Restriction Enzyme Digest Variant Ratios were performed
as previously described [22,42], with fluorescent detec-
tion of amplification products by an Applied Biosystems
3100 Genetic Analyzer. MAPH involves hybridisation of
short amplifiable probes to genomic DNA immobilised
on a nylon filter. Following stringent washing, the bound
probes are released and amplified using a pair of primer
sites common to all probes. One primer is fluorescently
labelled so that the resulting PCR product can be run on a
capillary electrophoresis machine and quantified. The
area under the probe peak is directly proportional to the
number of sites for that probe in the immobilised
genomic DNA.
We constructed a set of MAPH probes consisting of test
probes mapping to individual beta-defensin genes and
reference probes that have been shown to be non-variable
in copy number [43]. The values for each test probe were
normalised for lane intensity against the reference probes,
and duplicate values plotted on a scatterplot and the Pear-
son correlation coefficient (r) calculated for each probe
across all tested samples. Scatterplots were also visually
inspected for outliers along the x = y diagonal axis. The
error rate was calculated by extrapolating the mean (μ = 1)
and standard deviation (σ = 0.08) of the duplicate sam-
ples of the reference probes to a predicted distribution of
measurements of duplication alleles with mean 1.5 μ and
standard deviation σ √ 1.5. Assuming a normal Gaussian
distribution, the probability of obtaining a value less than
1.3 (threshold for detecting duplications) from this distri-
bution is 2%.
The MAPH probe for DEFB127 did not give reproducible
results, and copy number variation at this gene was
excluded by performing REDVR on both the G31R
(rs12624954) and R71S (rs16995685) polymorphic sites.
REDVR involves PCR amplification across a restriction
enzyme site that varies between copies with a pair of prim-
ers, one being fluorescently labelled. This is followed by
restriction enzyme digestion and quantification of the two
peaks produces a ratio of cut to uncut products.
Haplotype determination
In order to determine haplotypes at DEFB127 from indi-
viduals who were heterozygous at more than one site,
allele specific PCR (AS-PCR) was performed using primers
with a 3'LNA base (Sigma-Proligo), which enhances pyri-
midine-purine mismatch determination [44]. Polymor-
phic sites used for AS-PCR are shown in supplementary
table 4. PCR products from both haplotypes were
sequenced.
For DEFB132, haplotypes were inferred from the diplo-
type data using the maximum-likelihood Bayesian
approach implemented by PHASE2 [45]. 13 samples were
heterozygous at two or more sites, and the phase proba-
bilities of all inferred sites was >0.95, with the exception
of four sites where the probabilities were 0.93 and 0.94.
For comparison, inferring haplotypes at DEFB127 from
the diplotype data resulted in 19 inferred sites with phase
probabilities less than 0.90. This is likely to be due to the
high number of haplotypes in Africans that were observed
in only one individual, and that differ from each other by
more than one site (supplementary figure 4a).
Interspecific analyses
Putative orthologous DNA sequence of each beta-
defensin was aligned by ClustalW using the default
parameters except a low gap extension penalty (0.05),
using the computer server at the European Bioinformatics
Institute (see Availability and requirements section for
URL). Phylogenetic trees were constructed from align-
ments by maximum-likelihood using the program
DnaML, part of the Phylip 3.6 suite of programs [46]. Fol-
lowing assembly of the coding sequences of each gene, the
protein sequence was aligned using ClustalW with default
parameters. This protein alignment was used to inform
the codon-based alignment used by the maximum likeli-
hood codon-based selection program PAML 3.14 [16].
Start and stop codons, and deletions, were removed from
the codon alignment.
An unrooted tree representing an accepted phylogeny of
the primates [47] was used in PAML – branch lengths were
not specified, and it was assumed that there was no differ-
ence in selective pressures across the branches (one ω
ratio). The proximity of nodes for human, chimpanzee
and gorilla raises the possibility that the phylogeny for
each gene is not the same as the phylogeny of the species,
where gorillas diverged first. In order to clarify the phylog-
eny at DEFB127, we resequenced the 3.2 kb spanning the
gene in chimpanzee and gorilla. There were no phyloge-
netically informative sites that allowed us to unambigu-
ously determine the human-chimpanzee-gorilla
branching pattern. Therefore the tree was described ini-
tially as a trifurcation in input files and the branching pat-
tern allowed to vary as a free parameter so that results were
not dependant on constraining the tree to a specific
branch pattern at this node.
By fitting the data to two likelihood models in PAML, M1a
and M2a, we have a test of whether positive selection, as
defined by ω >1, has acted on a gene. M1a is the model
assuming a null hypothesis that all codons fall into twoBMC Evolutionary Biology 2008, 8:113 http://www.biomedcentral.com/1471-2148/8/113
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classes: either evolving neutrally (ω = 1) or with mild puri-
fying selection (0< ω <1). M2a allows codons to fall into
another class: those showing positive selection (ω >1).
Therefore, by comparing the log likelihood of the data fit-
ting model M1a with the log likelihood of the data fitting
model M2a, a significance level is obtained testing the
hypothesis that certain codons are under positive selec-
tion. The significance value is derived by calculating 2 ×
(log likelihood M1a – log likelihood M2a), and compar-
ing the figure with a χ2 distribution with 2 degrees of free-
dom. P < 0.05 is regarded as significant, with a Holm
correction for multiple tests [48].
Identification of codons that have experienced selection
were identified by a Bayes Empirical Bayes method imple-
mented in PAML [49]. Briefly, the method calculates the
posterior probability that a given codon falls into the ω >1
class, as identified by the M2a model, accounting for the
maximum-likelihood estimate sampling errors of the
parameters in the model. Ancestral sequence reconstruc-
tion at each node, with probabilities at each codon site, is
also provided as output by PAML. Branch lengths on the
tree in figure 1 were generated by maximum likelihood
analysis of the coding sequence by baseml, part of PAML,
and the DEFB127 primate ancestral codon state was deter-
mined by a PAML codeml analysis of the primate
sequence, together with Canis familiaris and  Bos taurus
orthologues.
Population genetic analyses
All estimates were performed using Arlequin 3.0 [50] or
DnaSP 4.0 [51], with haplotype reduced-median network
diagrams drawn using Network 4 (see Availability and
requirements section for URL)[52]. Significance for the
Tajima's D [53], Fu's Fs [54] and Fay and Wu's H [24] were
generated by comparing the observed distribution against
a simulated distribution generated by 1000 runs of a coa-
lescent simulation algorithm, assuming population equi-
librium and selective neutrality, with θ taking the value of
θs which is calculated from the observed data (table 3).
Genetic differentiation was analysed initially by 2 × 2 con-
tingency tables of individual allele frequencies between
population groups, with significance assessed by Fisher's
Exact Test. A haplotype-based test, HST, was also used,
with significance assessed using a permutation test imple-
mented by DnaSP 4.0 [55].
Mismatch distributions were calculated using DnaSP 4.0.
The expected distribution for an expanding population
was generated using the following population parameters
justified by published studies on human autosomal neu-
tral loci [56]: pre-expansion population mutation param-
eter (θ0) = 1, post-expansion population mutation
parameter (θ1) = 10. The time from expansion (τ) was esti-
mated using the equation τ = 2 ut, where u is the haplo-
type mutation parameter and t is time in generations. u
was estimated from the human-chimpanzee divergence at
each locus, K, given a divergence time of 6 million years
[57]. In African populations the expansion time was 1
Mya reflecting the expansion after the speciation of mod-
ern humans, and in non-African populations the time was
100 kya, reflecting the expansion out of Africa, and a gen-
eration time of 20 years was assumed.
Availability and requirements
NCBI: http://www.ncbi.nlm.nih.gov/projects/SNP/
European Bioinformatics Institute: http://www.ebi.ac.uk/
tools/clustalw
Network 4: http://www.fluxus-engineering.com
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